Neurocrine Biosciences Inc (NASDAQ:NBIX)

102.72
Delayed Data
As of Jun 19
 +0.43 / +0.42%
Today’s Change
43.79
Today|||52-Week Range
104.53
+32.39%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close102.29
Today’s open101.84
Day’s range101.79 - 104.53
Volume542,369
Average volume (3 months)754,483
Market cap$8.2B
Data as of 4:00pm ET, 06/19/2018

Growth & Valuation

Earnings growth (last year)+0.61%
Earnings growth (this year)+85.99%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+977.51%
P/E ratioNM
Price/Sales42.29
Price/Book21.72

Competitors

----
BLUEbluebird bio Inc+1.15+0.65%
TECHBio-Techne Corp-0.12-0.07%
EXASExact Sciences Corp-0.47-0.67%
Data as of 4:00pm ET, 06/19/2018

Financials

Next reporting dateAugust 1, 2018
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$161.6M
Annual profit (last year)-$142.5M
Net profit margin-88.19%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Kevin Charles Gorman
Chief Financial Officer
Matthew C. Abernethy
Corporate headquarters
San Diego, California

Forecasts